Industries > Pharma > Pharmaceutical Contract Manufacturing Market 2017-2027

Pharmaceutical Contract Manufacturing Market 2017-2027

Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages

PUBLISHED: 02 February 2017
PAGES: 235
PRODUCT CODE: PHA0167

Clear
WOOCS 2.2.1
SKU: PHA0167 Categories: , ,

The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 6.4% in the first half of the forecast period and CAGR of 5.7% in the second half of the forecast period. The market is estimated at $88bn in 2021 and $124bn in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 235-page report you will receive 82 tables and 61 figures– all unavailable elsewhere.

The 235-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Pharmaceutical Contract Manufacturing Market 2017-2027

Report Scope
Global Pharmaceutical Contract Manufacturing Market forecasts from 2017-2027

Submarket forecasts at world level, from 2017-2027:
Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products
Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types
Other applications of outsourced production – other related services

Revenue forecasts from 2017-2027, for 12 countries:
– United States (US)
– EU5: Germany, France, the UK, Italy and Spain
– BRIC: Brazil, Russia, India and China
– South Korea
– Japan

• Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry

Qualitative Analysis from a CMO Perspective 2016-2027

Qualitative Analysis from a Client Perspective 2016-2027

Visiongain’s study is intended for anyone requiring commercial analyses for the Pharmaceutical Contract Manufacturing Market. You find data, trends and predictions.

Buy our report today Pharmaceutical Contract Manufacturing Market 2017-2027: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market 2017-2027


Latest Pharma news

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

READ

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

READ

Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2022-2032

To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.

05 January 2022

READ

Categories